1.
AIDS Res Hum Retroviruses
; 34(11): 907-908, 2018 11.
Article
En
| MEDLINE
| ID: mdl-29929374
Anti-HIV Agents/therapeutic use , Cognitive Dysfunction/complications , Cognitive Dysfunction/epidemiology , Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/therapeutic use , HIV Infections/complications , HIV Infections/drug therapy , Adult , Anti-HIV Agents/adverse effects , Anti-HIV Agents/blood , Antiretroviral Therapy, Highly Active , Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/adverse effects , Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/blood , Female , HIV , HIV Infections/psychology , Humans , Male , Medication Adherence , Mental Status and Dementia Tests , Middle Aged , Prevalence , Risk Factors